Antibody-based CCR5 blockade protects Macaques from mucosal SHIV transmission
CCR5 is a co-receptor for many transmitted HIV strains. Here, the authors show that biweekly injection of the CCR5-specific antibody Leronlimab protects rhesus macaques against infection following repeated intrarectal challenges of a CCR5-tropic SHIV.
Guardado en:
Autores principales: | Xiao L. Chang, Gabriela M. Webb, Helen L. Wu, Justin M. Greene, Shaheed Abdulhaqq, Katherine B. Bateman, Jason S. Reed, Cleiton Pessoa, Whitney C. Weber, Nicholas Maier, Glen M. Chew, Roxanne M. Gilbride, Lina Gao, Rebecca Agnor, Travis Giobbi, Jeffrey Torgerson, Don Siess, Nicole Burnett, Miranda Fischer, Oriene Shiel, Cassandra Moats, Bruce Patterson, Kush Dhody, Scott Kelly, Nader Pourhassan, Diogo M. Magnani, Jeremy Smedley, Benjamin N. Bimber, Nancy L. Haigwood, Scott G. Hansen, Timothy R. Brown, Lishomwa C. Ndhlovu, Jonah B. Sacha |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e057d02dc1bf44278b9075dfe29c62e7 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Single-dose bNAb cocktail or abbreviated ART post-exposure regimens achieve tight SHIV control without adaptive immunity
por: Mariya B. Shapiro, et al.
Publicado: (2020) -
Evidence for persistence of the SHIV reservoir early after MHC haploidentical hematopoietic stem cell transplantation
por: Lucrezia Colonna, et al.
Publicado: (2018) -
Cell Wall Composition of Hemp Shiv Determined by Physical and Chemical Approaches
por: Maya-Sétan Diakité, et al.
Publicado: (2021) -
CCR5 Receptor Occupancy Analysis Reveals Increased Peripheral Blood CCR5+CD4+ T Cells Following Treatment With the Anti-CCR5 Antibody Leronlimab
por: Xiao L. Chang, et al.
Publicado: (2021) -
Griffithsin carrageenan fast dissolving inserts prevent SHIV HSV-2 and HPV infections in vivo
por: Nina Derby, et al.
Publicado: (2018)